"> Novel Drosophila tumor necrosis factor class molecule (
    1.
    发明申请
    Novel Drosophila tumor necrosis factor class molecule ("DmTNF") and variants thereof 审中-公开
    新型果蝇肿瘤坏死因子分子(“DmTNF”)及其变体

    公开(公告)号:US20060147974A1

    公开(公告)日:2006-07-06

    申请号:US11345126

    申请日:2006-02-01

    CPC分类号: C07K14/525 A01K2217/05

    摘要: The present invention provides novel polynucleotides encoding Drosophila DmTNF polypeptides, fragments and homologs thereof. The present invention also is directed to novel polynucleotides encoding two Drosophila DmTNF variants, DmTNFv1 and DmTNFv2 polypeptides, fragments and homologs thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, in addition to methods of genetically modifying Drosophila or cultured cells to express or mis-express DmTNF, DmTNFv1, or DmTNFv2. The invention also relates to the use of such modified insects or cells to characterize DmTNF activity, identify TNF-like genes and/or genes implicated in modulating TNF, characterize TNF signaling pathways, and/or to identify modulators of DmTNF activity.

    摘要翻译: 本发明提供了编码果蝇DmTNF多肽的新型多核苷酸,其片段和同系物。 本发明还涉及编码两种果蝇DmTNF变体,DmTNFv1和DmTNFv2多肽的新型多核苷酸,其片段和同系物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 除了遗传修饰果蝇或培养细胞以表达或错误表达DmTNF,DmTNFv1或DmTNFv2的方法之外,本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。 本发明还涉及这种修饰的昆虫或细胞用于表征DmTNF活性,鉴定涉及调节TNF,表征TNF信号传导途径和/或鉴定DmTNF活性调节剂的TNF-样基因和/或基因的用途。

    "> Drosophila tumor necrosis factor class molecule (
    2.
    发明申请
    Drosophila tumor necrosis factor class molecule ("DmTNFv2") 有权
    果蝇肿瘤坏死因子分子(“DmTNFv2”)

    公开(公告)号:US20050227283A1

    公开(公告)日:2005-10-13

    申请号:US11142736

    申请日:2005-06-01

    CPC分类号: C07K14/525 A01K2217/05

    摘要: The present invention provides novel polynucleotides encoding Drosophila DmTNF polypeptides, fragments and homologs thereof. The present invention also is directed to novel polynucleotides encoding two Drosophila DmTNF variants, DmTNFv1 and DmTNFv2 polypeptides, fragments and homologs thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, in addition to methods of genetically modifying Drosophila or cultured cells to express or mis-express DmTNF, DmTNFv1, or DmTNFv2. The invention also relates to the use of such modified insects or cells to characterize DmTNF activity, identify TNF-like genes and/or genes implicated in modulating TNF, characterize TNF signaling pathways, and/or to identify modulators of DmTNF activity.

    摘要翻译: 本发明提供了编码果蝇DmTNF多肽的新型多核苷酸,其片段和同系物。 本发明还涉及编码两种果蝇DmTNF变体,DmTNFv1和DmTNFv2多肽的新型多核苷酸,其片段和同系物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 除了遗传修饰果蝇或培养细胞以表达或错误表达DmTNF,DmTNFv1或DmTNFv2的方法之外,本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。 本发明还涉及这种修饰的昆虫或细胞用于表征DmTNF活性,鉴定涉及调节TNF,表征TNF信号传导途径和/或鉴定DmTNF活性调节剂的TNF-样基因和/或基因的用途。

    Novel adenosine deaminase homolog
    3.
    发明申请

    公开(公告)号:US20060160128A1

    公开(公告)日:2006-07-20

    申请号:US11386902

    申请日:2006-03-22

    摘要: This invention provides a novel isolated polynucleotide sequence, called ADARP1 (adenosine deaminase related protein 1), that displays significant homology to the adenosine deaminase (ADA) gene. Also provided is the amino acid sequence of the ADARP1 polypeptide encoded by the polynucleotide of the invention. The RNA for this novel gene is found in variety of tissues, with higher levels observed in the heart, testes, and skeletal muscle compared with others tested. Based on amino acid sequence homology, the ADARP1 protein will likely display the catalytic activity characteristic of ADA. This newly found ADARP1 gene and its encoded product may be useful in the treatment of immunodeficiencies, including severe combined immunodeficiency disease (SCID) and other ADA deficiencies, treatment of male reproductive disorders, testicular disorders and musclo-skeletal disorders.

    Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
    4.
    发明申请
    Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 有权
    编码HM74的新型人G蛋白偶联受体变体的多核苷酸HGPRBMY74

    公开(公告)号:US20050227238A1

    公开(公告)日:2005-10-13

    申请号:US10800249

    申请日:2004-03-12

    CPC分类号: C07K14/705

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY74 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY74 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码HGPRBMY74多肽,其片段和同源物的新型多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY74多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof
    5.
    发明申请
    Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof 有权
    编码两种新型人G蛋白偶联受体的多核苷酸HGPRBMY28和HGPRBMY29及其剪接变体

    公开(公告)号:US20080064094A1

    公开(公告)日:2008-03-13

    申请号:US11890963

    申请日:2007-08-08

    IPC分类号: C12N5/00 C07K1/00 C07K16/00

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding splice variants of HGPRBMY29 polypeptides, HGPRBMY29v1 and HGPRBMY29v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY28, HGPRBMY29, HGPRBMY29v1, and HGPRBMY29v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供编码HGPRBMY28和HGPRBMY29多肽的新型多核苷酸,其片段及其同源物。 本发明还提供编码HGPRBMY29多肽,HGPRBMY29v1和HGPRBMY29v2的剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY28,HGPRBMY29,HGPRBMY29v1和HGPRBMY29v2多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
    6.
    发明申请
    Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1 有权
    人类含有亮氨酸的重复含有蛋白质主要在骨髓HLRRBM1中表达

    公开(公告)号:US20050203048A1

    公开(公告)日:2005-09-15

    申请号:US11107572

    申请日:2005-04-15

    摘要: The present invention provides novel polynucleotides encoding HLRRBM1 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HLRRBM1 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly immune diseases and/or disorders. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码HLRRBM1多肽的新型多核苷酸,其片段及其同源物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HLRRBM1多肽应用于诊断,治疗和/或预防与这些多肽,特别是免疫疾病和/或病症相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Novel human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
    7.
    发明申请
    Novel human G-protein coupled receptor, HGPRBMY29sv1 polypeptides 有权
    新型人G蛋白偶联受体HGPRBMY29sv1多肽

    公开(公告)号:US20050148016A1

    公开(公告)日:2005-07-07

    申请号:US11070456

    申请日:2005-03-02

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding splice variants of HGPRBMY29 polypeptides, HGPRBMY29v1 and HGPRBMY29v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY28, HGPRBMY29, HGPRBMY29v1, and HGPRBMY29v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供编码HGPRBMY28和HGPRBMY29多肽的新型多核苷酸,其片段及其同源物。 本发明还提供编码HGPRBMY29多肽,HGPRBMY29v1和HGPRBMY29v2的剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY28,HGPRBMY29,HGPRBMY29v1和HGPRBMY29v2多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Polynucleotide encoding a novel human G-protein coupled receptor, HBPRBMY39
    10.
    发明申请
    Polynucleotide encoding a novel human G-protein coupled receptor, HBPRBMY39 有权
    编码新型人G蛋白偶联受体的多核苷酸HBPRBMY39

    公开(公告)号:US20070026448A1

    公开(公告)日:2007-02-01

    申请号:US11515921

    申请日:2006-09-05

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY39 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY39 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码HGPRBMY39多肽的新型多核苷酸,其片段及其同源物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY39多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。